Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Definium Therapeutics, Inc.

Medicinal Chemicals & Botanical Products · New York, NY, United States

  1. PrincipalsBrandi RobertsChief Financial OfficerDaniel KarlinChief Medical OfficerMark SullivanChief Legal Officerand 3 more
  2. CompanyDefinium Therapeutics, Inc.New York, NY, United States
  3. Phone line+1 (212) 220-6633General business
Request a quotedefiniumtx.com ↗

Definium Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker DFTX) classified under SIC 2833: Medicinal Chemicals & Botanical Products.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2833 — Medicinal Chemicals & Botanical Products — SEC EDGAR company submissions

People 6

Chief executive

Robert BarrowChief Executive Officer

Chair & board

Roger AdsettDirector (Board)

Finance

Brandi RobertsChief Financial Officer

Sales & commercial

Matthew T. WileyChief Commercial Officer

Legal

Mark SullivanChief Legal Officer
Everyone else on file (1)
Daniel KarlinChief Medical Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Brandi Roberts — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Matthew T. Wiley — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Daniel Karlin — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Mark Sullivan — Chief Legal Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers